FindTrial
Sign In

Comparison of different chemiluminecence immunoassay analyzers for determination of serum thyroglobulin in patients with differentiated thyroid cancer

Comparison of different chemiluminecence immunoassay analyzers for determination of serum thyroglobulin in patients with differentiated thyroid cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17013657
Enrollment
Unknown
Registered
2017-12-03
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

differentiated thyroid cancer

Interventions

Gold Standard:The imaging diagnosis and diagnostic criteria raised by ATA guidelines
Index test:thyroglobulin&#32
and&#32
thyroglobulin&#32
antibody

Sponsors

Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients with differentiated thyroid cancer who had undergo the total thyroidectomy, and they continued to undergo regular follow-up in our hospital, meanwhile, their serum thyroxin levels were detected in our clinical lab

Exclusion criteria

Exclusion criteria: The patients without differentiated thyroid cancer

Design outcomes

Primary

MeasureTime frame
SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactLu Hankui

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

luhankui@sina.com+86 18930177465

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026